Caxton Associates LLP Purchases New Position in Dolby Laboratories $DLB

Caxton Associates LLP purchased a new stake in Dolby Laboratories (NYSE:DLB) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,814 shares of the electronics maker’s stock, valued at approximately $708,000.

Other large investors have also recently modified their holdings of the company. Alpine Bank Wealth Management purchased a new stake in shares of Dolby Laboratories in the first quarter valued at approximately $25,000. MAI Capital Management increased its position in shares of Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 162 shares in the last quarter. Cheviot Value Management LLC acquired a new position in shares of Dolby Laboratories during the first quarter worth $27,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Dolby Laboratories during the first quarter worth $29,000. Finally, Global X Japan Co. Ltd. acquired a new position in shares of Dolby Laboratories during the first quarter worth $51,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on DLB. Tigress Financial upped their price target on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Rosenblatt Securities reaffirmed a “buy” rating and set a $95.00 price target on shares of Dolby Laboratories in a research report on Friday, August 1st. Robert W. Baird initiated coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Finally, Baird R W raised Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.75.

Dolby Laboratories Price Performance

NYSE DLB opened at $71.01 on Thursday. The stock’s fifty day moving average price is $73.88 and its 200 day moving average price is $75.66. Dolby Laboratories has a 1 year low of $68.24 and a 1 year high of $89.66. The company has a market cap of $6.81 billion, a price-to-earnings ratio of 26.01 and a beta of 0.93.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.06. The firm had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The firm’s revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Research analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, August 12th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 48.35%.

Insider Activity

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $72.31, for a total value of $1,807,750.00. Following the sale, the chief executive officer directly owned 114,725 shares in the company, valued at $8,295,764.75. This represents a 17.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 99,366 shares of company stock worth $7,352,963 over the last ninety days. 38.39% of the stock is owned by insiders.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.